missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30146281

RAIDD/CRADD Antibody (14G8), CoraFluor™ 1, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-42688CL1

Product Code. 30146281

  • € 965.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

RAIDD/CRADD Monoclonal antibody specifically detects RAIDD/CRADD in Human samples. It is validated for ELISA,Western Blot,Immunocytochemistry/Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

RAIDD/CRADD
Monoclonal
CoraFluor 1
CASP2 and RIPK1 domain containing adaptor with death domain, Caspase and RIP adapter with death domain, caspase and RIP adaptor with death domain, death domain containing protein CRADD, death domain-containing protein CRADD, MGC9163, RAIDDdeath adaptor molecule RAIDD, RIP-associated ICH1/CED3-homologous protein with death domain, RIP-associated protein with a death domain
Recombinant human RAIDD/CRADD (1-199aa) purified from E. coli
0.1 mL
Apoptosis, Cancer, Cell Biology, Tumor Suppressors
8738
Store at 4°C in the dark. Do not freeze.
IgG1a κ
ELISA, Western Blot, Immunocytochemistry/Immunofluorescence
14G8
PBS
Mouse
Protein A purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.